𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of T-γ lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor

✍ Scribed by David F. Lang; C. S. Rosenfeld; H. S. Diamond; R. K. Shadduck; Z. R. Zeigler

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
194 KB
Volume
40
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eosinophilia resulting from administrati
Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-γ lymphoproliferative disease
✍ R. Gonzales-Chambers; Dr. C. Rosenfeld; A. Winkelstein; L. Dameshek 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

A therapeutic trial of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was attempted in a patient with neutropenia and frequent infections secondary to T-y lymphoproliferative disease (T-y LPD). During the 14 days of subcutaneous rhGM-CSF (500 kg/m2/day), the absolute e

Short term treatment with Escheria coli
Short term treatment with Escheria coli recombinant human granulocyte-macrophage–colony stimulating factor prior to chemotherapy for Hodgkin disease
✍ M. Aglietta; F. Montemurro; F. Fagioli; C. Volta; B. Botto; M. Cantonetti; V. Ra 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## BACKGROUND. Granulocyte-macrophage-colony stimulating factor (GM-CSF) administration stimulates the proliferation of hemopoietic progenitors. Shortly (48 -96 hours) after its discontinuation, feedback phenomena occur and the progenitor proliferation rate drops below baseline levels. As the quies

Treatment of severe aplastic anemia with
Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin
✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti

Effect of recombinant human granulocyte
Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia
✍ Mart�nez-Jaramillo, Guadalupe; G�mez-Morales, Enrique; Mayani, Hector 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The hematopoietic system in patients with aplastic anemia (AA) shows both quantitative and qualitative deficiencies, i.e., reduced numbers of hematopoietic progenitor cells (HPC) and impaired HPC proliferation in long-term marrow cultures (LTMC). Since recombinant human granulocyte macrophage-colony